‌

US Patent 9554987 Methods and formulations for treating sialic acid deficiencies

Patent 9554987 was granted and assigned to Ultragenyx Pharmaceutical on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Ultragenyx Pharmaceutical

Current Assignee

Ultragenyx Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

95549870

Patent Inventor Names

Emil Kakkis0

Date of Patent

January 31, 2017

Patent Application Number

137451060

Date Filed

January 18, 2013

Patent Primary Examiner

‌

James Rogers

Patent abstract

The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9554987 Methods and formulations for treating sialic acid deficiencies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API